22h
The Print on MSNHow reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...
Bonus Jul 13, 2017 Jul 14, 2017 May 29, 2017 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Jul 11, 2013 Jul 13, 2013 May 22, 2013 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Oct 01, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results